Real-time enrollment status for this fabry disease clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 12:38 PM UTC
| NCT Number | NCT06270316 |
| Recruiting Status | Recruiting |
| Condition | Fabry Disease |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 10 sites in the US |
| Sponsor | UniQure Biopharma B.V. |
| Last Updated on CT.gov | September 24, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT06270316 is currently recruiting participants. This phase1 study for fabry disease is actively seeking new participants at 10 locations across the United States. The study is sponsored by UniQure Biopharma B.V.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06270316 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06270316 was last updated 3 weeks ago (September 24, 2026). HelloStudys verifies this status automatically.